Latest Market News

Mesoblast reports positive FDA progress on accelerated approval for Revascor in ischemic heart failure and plans a pivotal trial to extend Ryoncil’s label to adults with graft versus host disease, while its US commercial launch outpaces expectations.

HITIQ has partnered exclusively with Shock Doctor to launch the PROTEQT instrumented mouthguard, aiming to transform concussion management worldwide. The company also initiates a $2.92 million rights issue to fuel this ambitious rollout.

EV Resources Limited has finalized its acquisition of a 70% interest in the Los Lirios Antimony Mine in Oaxaca, Mexico, marking a strategic move to bolster critical mineral supply in the Americas. The company is advancing ore testing and plans to develop processing capabilities aligned with local community priorities.

Macquarie Group Limited has announced a quarterly ordinary dividend of AUD 1.7239 per CAP Note security, payable in September 2025, with partial franking and a total distribution rate of 6.84% per annum.

EVE Health Group has completed its acquisition of Nextract Pty Ltd, positioning itself to enter the lucrative erectile dysfunction and dysmenorrhea markets with innovative drug delivery technologies.

AGL Energy has confirmed it is reviewing its 20% stake in Tilt Renewables following recent media speculation, though no sale discussions are underway. The outcome remains uncertain as the company conducts preliminary assessments.

AnteoTech secures a significant purchase order from the Serum Institute of India, driving its Life Sciences unit toward a projected 130% sales increase in FY2025 despite some project delays.

BPH Global Ltd has completed its second seaweed sale under a strategic partnership in Indonesia, marking steady progress in its supply network expansion and operational execution.

JPMorgan Asset Management has announced the June 2025 distribution and provided detailed tax attribution estimates for its US 100Q Equity Premium Income Active ETF, highlighting key income components and withholding tax implications.

Kinetiko Energy has completed a $2.2 million placement, supported by directors and major shareholders, to advance its gas exploration and production testing in South Africa’s Mpumalanga Province. Initial production test results are expected in July 2025.

Monash IVF Group has announced the resignation of CEO Michael Knaap, with CFO Malik Jainudeen stepping in as Acting CEO during the leadership transition.

Lynch Group reports robust FY25 trading results, driven by strong Australian and Chinese markets, and sets optimistic full-year revenue and earnings guidance.